Supporting Professionals in Practice

Considering the relationship between oral care and overall health, OraPharma has carefully developed a well-rounded product portfolio of comprehensive solutions that address patients’ oral health concerns. From our flagship product, ARESTIN (minocycline HCl) Microspheres, 1 mg, to our continued commitment to broaden our portfolio and partnerships, OraPharma stays dedicated to partnering with dental professionals to offer products and solutions that improve their practices and patient care.

Image of three dental professionals

Advancing Professional Education

Beyond the development of new products, advancing oral care requires support and education for the professionals who use those products. That’s one of the reasons we provide dental professionals with information and tools to educate patients on oral healthcare.

We also partner with leading academic institutions and professional associations to create programs that clinically benefit both dental professionals and students. Through the ARESTIN Student Access program, we provide education and experience to dental and dental hygiene students at schools across the country.

A History of Helping People

With over two decades in the oral health space, OraPharma has continued to grow as a company and expand our portfolio.

Image of the ARESTIN (minocycline HCl) Microspheres, 1 mg logo

In 1996, OraPharma was founded as a specialty pharmaceutical company dedicated to oral healthcare. Our flagship product, ARESTIN, was approved by the FDA in 2001.

Johnson & Johnson

OraPharma operated as a subsidiary of Johnson & Johnson.

Image of the Valeant Pharmaceuticals International logo

OraPharma was acquired by Valeant Pharmaceuticals International, Inc. from a strategic private equity firm. Valeant Pharmaceuticals International, Inc. (now Bausch Health Companies Inc.) is a multi-national specialty pharmaceutical company with a diverse product portfolio focused on branded pharmaceuticals, branded generics, and over-the-counter (OTC) products.

Image of the NeutraSal logo

OraPharma expanded our portfolio with the acquisition of NeutraSal. NeutraSal (supersaturated calcium phosphate rinse), a prescription oral rinse, has been added to the OraPharma family of products.

Datum Dental

Through a partnership with Datum Dental Ltd., we are continuing our mission to offer innovative products for guided bone regeneration (GBR) and guided tissue regeneration (GTR).

Egalet

OraPharma entered into a partnership with Egalet to co-promote a non-opioid pain relief option.